K. Dekker

Jeroen Bosch Ziekenhuis

Papers

2

Total Citations

10

H-Index

2

About

K. Dekker is a leading surgical oncologist whose research focuses on advancing the treatment of bladder cancer, particularly through the comparative evaluation of robot-assisted versus open radical cystectomy. Their major contributions center on providing robust, real-world evidence from the Netherlands to assess the intermediate-term survival outcomes of these surgical approaches for patients with muscle-invasive and high-risk non-muscle invasive bladder cancer. Dekker’s work has been instrumental in clarifying the oncological efficacy of robotic surgery, demonstrating non-inferior survival rates compared to traditional open procedures. With their most-cited paper accumulating 8 citations, Dekker’s research has directly influenced clinical decision-making by reassuring surgeons and patients that robot-assisted techniques can offer comparable intermediate-term survival without compromising cancer control. By leveraging national registry data, Dekker has helped bridge the gap between randomized trial findings and everyday practice, offering a nuanced understanding of surgical outcomes. Their contributions are vital for guiding treatment protocols and improving patient counseling in urologic oncology, making them a respected voice in the ongoing evolution of minimally invasive bladder cancer surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
10
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands
8 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 58
🏛 Institutions: Jeroen Bosch Ziekenhuis

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago